Patten Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-31
Closed -$4K 594
2018
Q4
$4K Buy
+31
New +$5.08K ﹤0.01% 500
2017
Q4
Sell
-93
Closed -$19K 652
2017
Q3
$19K Sell
93
-73
-44% -$17K 0.01% 425
2017
Q2
$40K Hold
166
0.02% 347
2017
Q1
$40K Buy
166
+20
+14% +$4.66K 0.02% 332
2016
Q4
$31K Sell
146
-125
-46% -$25.9K 0.01% 356
2016
Q3
$63K Sell
271
-73
-21% -$17.8K 0.03% 286
2016
Q2
$79.5K Sell
344
-331
-49% -$76.3K 0.04% 257
2016
Q1
$181K Sell
675
-184
-21% -$52.7K 0.09% 170
2015
Q4
$268K Sell
859
-132
-13% -$39.3K 0.13% 146
2015
Q3
$269K Hold
991
0.14% 141
2015
Q2
$301K Sell
991
-18
-2% -$5.37K 0.14% 140
2015
Q1
$300K Buy
+1,009
New +$288K 0.15% 141

Other funds holding AGN

Patten Group's AGN Position: Q1 2019 in Review

Patten Group sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 31 shares — an estimated $4K sold.

Patten Group first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $301K in Q2 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Patten Group reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Patten Group sold 31 Allergan plc shares in Q1 2019, an estimated $4K.
  • Patten Group first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • Patten Group's Allergan plc position peaked at $301K in Q2 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.